Probucol

This classification denotes an anti-lipidemic agent with the molecular formula C31H48O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P3CTH044XJ, chemically known as 4,4-(isopropylidenedithio)bis(2,6-di-tert-butylphenol) but generally known as probucol, which bears US NIH Compound Identifier 4912. European Medicines Agency schedules Probucol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10054MIG. The term PROBUCOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules probucol in its Anatomical Therapeutic Chemical (ATC) Classification. PROBUCOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule probucol under HS 29309085 and SITC 51549. As of Q4 2014, PROBUCOL remains the US FDA Preferred Term for this commodity. Probucol bears US NLM identifiers UMLS ID C0033215 and NCI Concept Code C66470. SMILES: S(c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)C(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)(C)C.